Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04565496 |
| Title | Phase 2 Study of Neoadjuvant PEMbrolizumab Before Radical PROstatectomy in High-risk Prostate Cancer Patients (PEM-PRO) |
| Acronym | PEM-PRO |
| Recruitment | Unknown status |
| Gender | male |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | IRCCS San Raffaele |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | ITA |